Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Cancer and Metastasis Reviews
Erschienen in: Cancer and Metastasis Reviews 3/2019

26.11.2019

Exosomes as a storehouse of tissue remodeling proteases and mediators of cancer progression

verfasst von: Alakesh Das, Vishnu Mohan, Venkat Raghavan Krishnaswamy, Inna Solomonov, Irit Sagi

Erschienen in: Cancer and Metastasis Reviews | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Rapidly increasing scientific reports of exosomes and their biological effects have improved our understanding of their cellular sources and their cell-to-cell communication. These nano-sized vesicles act as potent carriers of regulatory bio-macromolecules and can induce regulatory functions by delivering them from its source to recipient cells. The details of their communication network are less understood. Recent studies have shown that apart from delivering its cargo to the cells, it can directly act on extracellular matrix (ECM) proteins and growth factors and can induce various remodeling events. More importantly, exosomes carry many surface-bound proteases, which can cleave different ECM proteins and carbohydrates and can shed cell surface receptors. These local extracellular events can modulate signaling cascades, which consequently influences the whole tissue and organ. This review aims to highlight the critical roles of exosomal proteases and their mechanistic insights within the cellular and extracellular environment.
Literatur
1.
Théry, C., Zitvogel, L., & Amigorena, S. (2002). Exosomes: Composition, biogenesis and function. Nature Reviews. Immunology, 2(8), 569–579.PubMedCrossRef
2.
Nawaz, M., et al. (2018). Extracellular Vesicles and Matrix Remodeling Enzymes: The Emerging Roles in Extracellular Matrix Remodeling, Progression of Diseases and Tissue Repair. Cells, 7(10), 167.PubMedCentralCrossRef
3.
Li, S. P., Lin, Z. X., Jiang, X. Y., & Yu, X. Y. (2018). Exosomal cargo-loading and synthetic exosome-mimics as potential therapeutic tools. Acta Pharmacologica Sinica, 39(4), 542–551.PubMedPubMedCentralCrossRef
4.
Elsherbini, A., & Bieberich, E. (2018). Ceramide and Exosomes: A Novel Target in Cancer Biology and Therapy (Vol. 140). Elsevier Ltd.
5.
Williams, C., et al. (2018). Glycosylation of extracellular vesicles: current knowledge, tools and clinical perspectives. Journal of Extracellular Vesicles, 7(1).PubMedPubMedCentralCrossRef
6.
Williams, C., et al. (2019). Assessing the role of surface glycans of extracellular vesicles on cellular uptake. Scientific Reports, 9(1), 11920.PubMedPubMedCentralCrossRef
7.
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology, 9(6), 654–659.PubMedCrossRef
8.
Q. Liu et al., “Donor dendritic cell–derived exosomes promote allograft-targeting immune response,” vol. 126, no. 8, pp. 2805–2820, 2016.
9.
Fabbri, M., Paone, A., Calore, F., Galli, R., Croce, C. M., & Mediators, C. C. (2013). A new role for microRNAs, as ligands of Toll-like receptors Muller. RNA Biology, 10(2, no. February), 169–174.PubMedPubMedCentralCrossRef
10.
Thakur, B. K., Zhang, H., Becker, A., Matei, I., Huang, Y., Costa-Silva, B., Zheng, Y., Hoshino, A., Brazier, H., Xiang, J., Williams, C., Rodriguez-Barrueco, R., Silva, J. M., Zhang, W., Hearn, S., Elemento, O., Paknejad, N., Manova-Todorova, K., Welte, K., Bromberg, J., Peinado, H., & Lyden, D. (2014). Double-stranded DNA in exosomes: A novel biomarker in cancer detection. Cell Research, 24(6), 766–769.PubMedPubMedCentralCrossRef
11.
Kalluri, R., & Lebleu, V. S. (2016). Discovery of double-stranded genomic DNA in circulating exosomes. Cold Spring Harbor Symposia on Quantitative Biology, 81(1), 275–280.PubMedCrossRef
12.
Dourado, M. R., et al. (2019). Extracellular vesicles derived from cancer-associated fibroblasts induce the migration and invasion of oral squamous cell carcinoma. Journal of Extracellular Vesicles, 8(1).PubMedPubMedCentralCrossRef
13.
Hamam, D., Abdouh, M., Gao, Z. H., Arena, V., Arena, M., & Arena, G. O. (2016). Transfer of malignant trait to BRCA1 deficient human fibroblasts following exposure to serum of cancer patients. Journal of Experimental & Clinical Cancer Research, 35(1), 1–12.CrossRef
14.
Minciacchi, V. R., et al. Extracellular Vesicles in Cancer: Exosomes, Microvesicles and the Emerging Role of Large Oncosomes. Seminars in Cell & Developmental Biology, 40, 41–51.CrossRef
15.
McKelvey, K. J., Powell, K. L., Ashton, A. W., Morris, J. M., & McCracken, S. A. (2015). Exosomes: Mechanisms of uptake. Journal of Circulating Biomarkers, 4, 1–9.CrossRef
16.
Gonda, A., Kabagwira, J., Senthil, G. N., & Wall, N. R. (2019). Internalization of exosomes through receptor-mediated endocytosis. Molecular Cancer Research, 17(2), 337–347.PubMedCrossRef
17.
Maas, S. L. N., Breakefield, X. O., & Weaver, A. M. (2017). Extracellular vesicles: Unique intercellular delivery vehicles. Trends in Cell Biology, 27(3), 172–188.PubMedCrossRef
18.
Duijvesz, D., et al. (2013). Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer. PLoS One, 8(12), 1–10.CrossRef
19.
Huang, T., & Deng, C. X. (2019). Current progresses of exosomes as cancer diagnostic and prognostic biomarkers. International Journal of Biological Sciences, 15(1), 1–11.PubMedPubMedCentralCrossRef
20.
Shimoda, M., & Khokha, R. (2017). Metalloproteinases in extracellular vesicles. Biochimica et Biophysica Acta, Molecular Cell Research, 1864(11), 1989–2000.PubMedCrossRef
21.
Shimoda, M., & Khokha, R. (2013). Proteolytic factors in exosomes. Proteomics, 13(10–11), 1624–1636.PubMedCrossRef
22.
Das, A., Monteiro, M., Barai, A., Kumar, S., & Sen, S. (2017). MMP proteolytic activity regulates cancer invasiveness by modulating integrins. Scientific Reports, 7(1), 1–13.CrossRef
23.
Das, S. S. A., Kapoor, A., Mehta, G. D., & Ghosh, S. K. (2013). Extracellular Matrix Density Regulates Extracellular Proteolysis via Modulation of Cellular Contractility. Journal of Carcinogenesis and Mutagenesis, S13.
24.
Kapoor, A., Barai, A., Thakur, B., Das, A., Patwardhan, S. R., Monteiro, M., Gaikwad, S., Bukhari, A. B., Mogha, P., Majumder, A., de, A., Ray, P., & Sen, S. (2018). Soft drug-resistant ovarian cancer cells migrate via two distinct mechanisms utilizing myosin II-based contractility. Biochimica et Biophysica Acta, Molecular Cell Research, 1865(2), 392–405.PubMedCrossRef
25.
A. Haage and I. C. Schneider, “Cellular contractility and extracellular matrix stiffness regulate matrix metalloproteinase activity in pancreatic cancer cells,” pp. 1–11, 2014.
26.
Gong, Y., Chippada-Venkata, U. D., & Oh, W. K. (2014). Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression. Cancers (Basel), 6(3), 1298–1327.CrossRef
27.
Jiao, Y., et al. (2012). Matrix metalloproteinase-2 promotes αvβ3 integrin-mediated adhesion and migration of human melanoma cells by cleaving fibronectin. PLoS One, 7(7), e41591.PubMedPubMedCentralCrossRef
28.
Ginestra, A., Monea, S., Seghezzi, G., Dolo, V., Nagase, H., Mignatti, P., & Vittorelli, M. L. (1997). Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells. The Journal of Biological Chemistry, 272(27), 17216–17222.PubMedCrossRef
29.
Sung, B. H., & Weaver, A. M. (2017). Exosome secretion promotes chemotaxis of cancer cells. Cell Adhesion & Migration, 11(2), 187–195.CrossRef
30.
Dolo, V., et al. (1998). Selective localization of matrix metalloproteinase 9, β 1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells. Cancer Research, 58(19), 4468–4474.PubMed
31.
van der Vorst, E. P. C., de Jong, R. J., & Donners, M. M. P. C. (2018). Message in a Microbottle: Modulation of Vascular Inflammation and Atherosclerosis by Extracellular Vesicles. Frontiers in Cardiovascular Medicine, 5(January), 1–8.
32.
Li, H., Qiu, Z., Li, F., & Wang, C. (2017). The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis. Oncology Letters, 14(5), 5865–5870.PubMedPubMedCentral
33.
Minciacchi, V. R., Freeman, M. R., & Di Vizio, D. (2015). Extracellular vesicles in Cancer: Exosomes, microvesicles and the emerging role of large Oncosomes. Seminars in Cell & Developmental Biology, 40, 41–51.CrossRef
34.
Runz, S., Keller, S., Rupp, C., Stoeck, A., Issa, Y., Koensgen, D., Mustea, A., Sehouli, J., Kristiansen, G., & Altevogt, P. (2007). Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. Gynecologic Oncology, 107(3), 563–571.PubMedCrossRef
35.
Han, K. Y., Dugas-Ford, J., Seiki, M., Chang, J. H., & Azar, D. T. (2015). Evidence for the involvement of MMP14 in MMP2 processing and recruitment in exosomes of corneal fibroblasts. Investigative Ophthalmology and Visual Science, 56(9), 5323–5329.PubMedPubMedCentral
36.
Hakulinen, J., Sankkila, L., Sugiyama, N., Lehti, K., & Keski-Oja, J. (2008). Secretion of active membrane type 1 matrix metalloproteinase (MMP-14) into extracellular space in microvesicular exosomes. Journal of Cellular Biochemistry, 105(5), 1211–1218.PubMedCrossRef
37.
Meng, W., Hao, Y., He, C., Li, L., & Zhu, G. (2019). Exosome-orchestrated hypoxic tumor microenvironment. Molecular Cancer, 18(1), 1–14.CrossRef
38.
Sung, B. H., Ketova, T., Hoshino, D., Zijlstra, A., & Weaver, A. M. (2015). Directional cell movement through tissues is controlled by exosome secretion. Nature Communications, 6(May), 1–14.
39.
Shan, Y., et al. (2018). Hypoxia-Induced Matrix Metalloproteinase-13 Expression in Exosomes from Nasopharyngeal Carcinoma Enhances Metastases. Cell Death & Disease, 9(3).
40.
Groth, E., Pruessmeyer, J., Babendreyer, A., Schumacher, J., Pasqualon, T., Dreymueller, D., Higashiyama, S., Lorenzen, I., Grötzinger, J., Cataldo, D., & Ludwig, A. (2016). Stimulated release and functional activity of surface expressed metalloproteinase ADAM17 in exosomes. Biochimica et Biophysica Acta, Molecular Cell Research, 1863(11), 2795–2808.CrossRef
41.
Stoeck, A., Keller, S., Riedle, S., Sanderson, M. P., Runz, S., le Naour, F., Gutwein, P., Ludwig, A., Rubinstein, E., & Altevogt, P. (2006). A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44. The Biochemical Journal, 393(3), 609–618.PubMedPubMedCentralCrossRef
42.
Wanger, T. M., Dewitt, S., Collins, A., Maitland, N. J., Poghosyan, Z., & Knäuper, V. (2015). Differential regulation of TROP2 release by PKC isoforms through vesicles and ADAM17. Cellular Signalling, 27(7), 1325–1335.PubMedCrossRef
43.
Zaman, S., Jadid, H., Denson, A. C., & Gray, J. E. (2019). Targeting trop-2 in solid tumors: Future prospects. OncoTargets and Therapy, 12, 1781–1790.PubMedPubMedCentralCrossRef
44.
Tugutova, E. A., Tamkovich, S. N., Patysheva, M. R., Afanas’ev, S. G., Tsydenova, A. A., Grigor’eva, A. E., Kolegova, E. S., Kondakova, I. V., & Yunusova, N. V. (2019). Relation between tetraspanin- associated and tetraspanin- non- associated exosomal proteases and metabolic syndrome in colorectal cancer patients. Asian Pacific Journal of Cancer Prevention, 20(3), 809–815.PubMedCrossRefPubMedCentral
45.
Shimoda, M., Principe, S., Jackson, H. W., Luga, V., Fang, H., Molyneux, S. D., Shao, Y. W., Aiken, A., Waterhouse, P. D., Karamboulas, C., Hess, F. M., Ohtsuka, T., Okada, Y., Ailles, L., Ludwig, A., Wrana, J. L., Kislinger, T., & Khokha, R. (2014). Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state. Nature Cell Biology, 16(9), 889–901.PubMedCrossRef
46.
Hansen, H. P., et al. (2016). CD30 on extracellular vesicles from malignant Hodgkin cells supports damaging of CD30 ligand-expressing bystander cells with Brentuximab-Vedotin, in vitro. Oncotarget, 7(21), 30523–30535.PubMedPubMedCentralCrossRef
47.
Tauro, B. J., Mathias, R. A., Greening, D. W., Gopal, S. K., Ji, H., Kapp, E. A., Coleman, B. M., Hill, A. F., Kusebauch, U., Hallows, J. L., Shteynberg, D., Moritz, R. L., Zhu, H. J., & Simpson, R. J. (2013). Oncogenic H-Ras reprograms madin-Darby canine kidney (MDCK) cell-derived exosomal proteins following epithelial-mesenchymal transition. Molecular & Cellular Proteomics, 12(8), 2148–2159.CrossRef
48.
Yoneyama, T., Gorry, M., Sobo-Vujanovic, A., Lin, Y., Vujanovic, L., Gaither-Davis, A., Moss, M. L., Miller, M. A., Griffith, L. G., Lauffenburger, D. A., Stabile, L. P., Herman, J., & Vujanovic, N. L. (2018). ADAM10 sheddase activity is a potential lung-cancer biomarker. Journal of Cancer, 9(14), 2559–2570.PubMedPubMedCentralCrossRef
49.
Yang, M., Li, Y., Chilukuri, K., Brady, O. A., Boulos, M. I., Kappes, J. C., & Galileo, D. S. (2011). L1 stimulation of human glioma cell motility correlates with FAK activation. Journal of Neuro-Oncology, 105(1), 27–44.PubMedPubMedCentralCrossRef
50.
Tamkovich, S. N., Yunusova, N. V., Tugutova, E., Somov, A. K., Proskura, K. V., Kolomiets, L. A., Stakheyeva, M. N., Grigor’eva, A. E., Laktionov, P. P., & Kondakova, I. V. (2019). Protease cargo in circulating exosomes of breast cancer and ovarian cancer patients. Asian Pacific Journal of Cancer Prevention, 20(1), 255–262.PubMedCrossRefPubMedCentral
51.
Lee, H. D., Koo, B. H., Kim, Y. H., Jeon, O. H., & Kim, D. S. (2012). Exosome release of ADAM15 and the functional implications of human macrophage-derived ADAM15 exosomes. The FASEB Journal, 26(7), 3084–3095.PubMedCrossRef
52.
Webber, J., Stone, T. C., Katilius, E., Smith, B. C., Gordon, B., Mason, M. D., Tabi, Z., Brewis, I. A., & Clayton, A. (2014). Proteomics analysis of cancer exosomes using a novel modified aptamer-based array (somascantm) platform. Molecular & Cellular Proteomics, 13(4), 1050–1064.CrossRef
53.
Kato, T., et al. (2014). Exosomes from IL-1β stimulated synovial fibroblasts induce osteoarthritic changes in articular chondrocytes. Arthritis Research & Therapy, 16(4), 1–11.CrossRef
54.
Rana, S., Malinowska, K., & Zöller, M. (2013). Exosomal tumor microRNA modulates premetastatic organ cells. Neoplasia (United States), 15(3), 281–295.CrossRef
55.
McAtee, C. O., et al. (2019). Prostate tumor cell exosomes containing hyaluronidase Hyal1 stimulate prostate stromal cell motility by engagement of FAK-mediated integrin signaling. Matrix Biology, 78–79, 165–179.PubMedCrossRef
56.
Hong, Y., et al. (2018). Exosome as a vehicle for delivery of membrane protein therapeutics, PH20, for enhanced tumor penetration and antitumor efficacy. Advanced Functional Materials, 28(5), 1–9.CrossRef
57.
Genschmer, K. R., et al. (2019). Activated PMN Exosomes: Pathogenic Entities Causing Matrix Destruction and Disease in the Lung. Cell, 176(1–2), 113–126.e15.PubMedCrossRefPubMedCentral
58.
Bulloj, A., Leal, M. C., Xu, H., Castaño, E. M., & Morelli, L. (2010). Insulin-degrading enzyme sorting in exosomes: A secretory pathway for a key brain amyloid-β degrading protease. Journal of Alzheimer's Disease, 19(1), 79–95.PubMedCrossRef
59.
Sanderson, R. D., Bandari, S. K., & Vlodavsky, I. (2019). Proteases and glycosidases on the surface of exosomes: Newly discovered mechanisms for extracellular remodeling. Matrix Biology, 75–76, 160–169.PubMedCrossRef
60.
Thompson, C. A., Purushothaman, A., Ramani, V. C., Vlodavsky, I., & Sanderson, R. D. (2013). Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes. The Journal of Biological Chemistry, 288(14), 10093–10099.PubMedPubMedCentralCrossRef
61.
Murayama, T., Kataoka, H., Koita, H., Nabeshima, K., & Koono, M. (1991). Glycocalyceal bodies in a human rectal carcinoma cell line and their interstitial collagenolytic activities. Virchows Archiv. B, Cell Pathology Including Molecular Pathology, 60(1), 263–270.PubMedCrossRef
62.
Harris, D. A., Patel, S. H., Gucek, M., Hendrix, A., Westbroek, W., & Taraska, J. W. (2015). Exosomes released from breast cancer carcinomas stimulate cell movement. PLoS One, 10(3), 1–18.
63.
Cocucci, E., Racchetti, G., & Meldolesi, J. (2009). Shedding microvesicles: Artefacts no more. Trends in Cell Biology, 19(2), 43–51.PubMedCrossRef
64.
Whiteside, T. L. (2016). Tumor-Derived Exosomes and Their Role in Cancer Progression (Vol. 74, 1st ed.). Elsevier Inc..
65.
Edwards, D. R., Handsley, M. M., & Pennington, C. J. (2009). The ADAM metalloproteinases. Molecular Aspects of Medicine, 29(5), 258–289.CrossRef
66.
Wetzel, S., Seipold, L., & Saftig, P. (2017). The metalloproteinase ADAM10: A useful therapeutic target? Biochimica et Biophysica Acta, Molecular Cell Research, 1864(11), 2071–2081.PubMedCrossRef
67.
Levin, M., Udi, Y., Solomonov, I., & Sagi, I. (2017). Next generation matrix metalloproteinase inhibitors — Novel strategies bring new prospects. Biochimica et Biophysica Acta, Molecular Cell Research, 1864(11), 1927–1939.PubMedCrossRef
68.
Thathiah, A., Blobel, C. P., & Carson, D. D. (2003). Tumor necrosis factor-α converting enzyme/ADAM 17 mediates MUC1 shedding. The Journal of Biological Chemistry, 278(5), 3386–3394.PubMedCrossRef
69.
70.
Mishra, H. K., Ma, J., & Walcheck, B. (2017). Ectodomain shedding by ADAM17: Its ole in neutrophil recruitment and the Impairment of this process during sepsis. Frontiers in Cellular and Infection Microbiology, 7(APR), 1–10.
71.
Lambrecht, B. N., Vanderkerken, M., & Hammad, H. (2018). The emerging role of ADAM metalloproteinases in immunity. Nature Reviews. Immunology, 18(12), 745–758.PubMedCrossRef
72.
Chalaris, A., Adam, N., Sina, C., Rosenstiel, P., Lehmann-Koch, J., Schirmacher, P., Hartmann, D., Cichy, J., Gavrilova, O., Schreiber, S., Jostock, T., Matthews, V., Häsler, R., Becker, C., Neurath, M. F., Reiß, K., Saftig, P., Scheller, J., & Rose-John, S. (2010). Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice. The Journal of Experimental Medicine, 207(8), 1617–1624.PubMedPubMedCentralCrossRef
73.
Hartmann, D. (2002). The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. Human Molecular Genetics, 11(21), 2615–2624.PubMedCrossRef
74.
Purow, B. (2012). Notch signaling in embryology and Cancer. Advances in Experimental Medicine and Biology, 727, 174–315.CrossRef
75.
Mullooly, M., McGowan, P. M., Kennedy, S. A., Madden, S. F., Crown, J., O' Donovan, N., & Duffy, M. J. (2015). ADAM10: A new player in breast cancer progression? British Journal of Cancer, 113(6), 945–951.PubMedPubMedCentralCrossRef
76.
Li, B. X., et al. (2011). Effects of RNA interference-mediated gene silencing of JMJD2A on human breast cancer cell line MDA-MB-231 in vitro. Journal of Experimental & Clinical Cancer Research, 30(1), 1–9.CrossRef
77.
Feldinger, K., Generali, D., Kramer-Marek, G., Gijsen, M., Ng, T. B., Wong, J. H., Strina, C., Cappelletti, M., Andreis, D., Li, J. L., Bridges, E., Turley, H., Leek, R., Roxanis, I., Capala, J., Murphy, G., Harris, A. L., & Kong, A. (2014). ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer. Oncotarget, 5(16), 6633–6646.PubMedPubMedCentralCrossRef
78.
79.
Duffy, M. J., et al. (2011). The ADAMs family of proteases: New biomarkers and therapeutic targets for cancer? Clinical Proteomics, 8(1), 1–13.CrossRef
80.
“The ADAMTS metalloproteinases,” Biochem. J., vol. 27, pp. 15–27, 2011.
81.
Cal, S., & López-Otín, C. (2015). ADAMTS proteases and cancer. Matrix Biology, 44–46, 77–85.PubMedCrossRef
82.
Kelwick, R., Desanlis, I., Wheeler, G. N., & Edwards, D. R. (2015). The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family. Genome Biology, 16(1).
83.
Mead, T. J., du, Y., Nelson, C. M., Gueye, N. A., Drazba, J., Dancevic, C. M., Vankemmelbeke, M., Buttle, D. J., & Apte, S. S. (2018). ADAMTS9-regulated Pericellular matrix dynamics governs focal adhesion-dependent smooth muscle differentiation. Cell Reports, 23(2), 485–498.PubMedCrossRef
84.
El-Safory, N. S., Fazary, A. E., & Lee, C. K. (2010). Hyaluronidases, a group of glycosidases: Current and future perspectives. Carbohydrate Polymers, 81(2), 165–181.CrossRef
85.
McAtee, C. O., Barycki, J. J., & Simpson, M. A. (2014). Emerging roles for hyaluronidase in cancer metastasis and therapy. Advances in Cancer Research, 123(402), 1–34.PubMedPubMedCentral
86.
Josefsson, A., Adamo, H., Hammarsten, P., Granfors, T., Stattin, P., Egevad, L., Laurent, A. E., Wikström, P., & Bergh, A. (2011). Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcome. The American Journal of Pathology, 179(4), 1961–1968.PubMedPubMedCentralCrossRef
87.
Tan, J. X., et al. (2011). Upregulation of HYAL1 expression in breast cancer promoted tumor cell proliferation, migration, invasion and angiogenesis. PLoS One, 6(7).PubMedPubMedCentralCrossRef
88.
Kikuchi, S., Yoshioka, Y., Prieto-Vila, M., & Ochiya, T. (2019). Involvement of extracellular vesicles in vascular-related functions in cancer progression and metastasis. International Journal of Molecular Sciences, 20(10), 1–17.CrossRef
89.
Shao, C., et al. (2018). Role of hypoxia-induced exosomes in tumor biology. Molecular Cancer, 17(1), 1–8.CrossRef
90.
Lee, J. K., et al. (2013). Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells. PLoS One, (8, 12).
91.
Gopal, S. K., Greening, D. W., Hanssen, E. G., Zhu, H. J., Simpson, R. J., & Mathias, R. A. (2016). Oncogenic epithelial cell-derived exosomes containing Rac1 and PAK2 induce angiogenesis in recipient endothelial cells. Oncotarget, 7(15), 19709–19722.PubMedPubMedCentralCrossRef
92.
93.
Zeng, Z., et al. (2018). Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis. Nature Communications, 9(1).
94.
Tang, M. K. S., et al. (2018). Soluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface. Nature Communications, 9(1), 1–15.CrossRef
95.
Mao, Y., Keller, E. T., Garfield, D. H., Shen, K., & Wang, J. (2013). Stromal cells in tumor microenvironment and breast cancer. Cancer Metastasis Reviews, 32(1–2), 303–315.PubMedPubMedCentralCrossRef
96.
Ludwig, N., & Whiteside, T. L. (2018). Potential roles of tumor-derived exosomes in angiogenesis. Expert Opinion on Therapeutic Targets, 22(5), 409–417.PubMedPubMedCentralCrossRef
97.
Paggetti, J., Haderk, F., Seiffert, M., Janji, B., Distler, U., Ammerlaan, W., Kim, Y. J., Adam, J., Lichter, P., Solary, E., Berchem, G., & Moussay, E. (2015). Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts. Blood, 126(9), 1106–1117.PubMedPubMedCentralCrossRef
98.
Corrado, C., Saieva, L., Raimondo, S., Santoro, A., De Leo, G., & Alessandro, R. (2016). Chronic myelogenous leukaemia exosomes modulate bone marrow microenvironment through activation of epidermal growth factor receptor. Journal of Cellular and Molecular Medicine, 20(10), 1829–1839.PubMedPubMedCentralCrossRef
99.
Javidi-Sharifi, N., et al. (2019). Fgf2-fgfr1 signaling regulates release of leukemia-protective exosomes from bone marrow stromal cells. Elife, 8, 1–23.
100.
Purushothaman, A., Bandari, S. K., Liu, J., Mobley, J. A., Brown, E. A., & Sanderson, R. D. (2016). Fibronectin on the surface of myeloma cell-derived exosomes mediates exosome-cell interactions. The Journal of Biological Chemistry, 291(4), 1652–1663.PubMedCrossRef
101.
Yang, L., & Zhang, Y. (2017). Tumor-associated macrophages: from basic research to clinical application. Journal of Hematology & Oncology, 10(1), 58.CrossRef
102.
Zhang, W., Zhang, J., Cheng, L., Ni, H., You, B., Shan, Y., Bao, L., Wu, D., Zhang, T., Yue, H., & Chen, J. (2018). A disintegrin and metalloprotease 10-containing exosomes derived from nasal polyps promote angiogenesis and vascular permeability. Molecular Medicine Reports, 17(4), 5921–5927.PubMedPubMedCentral
103.
Chen, W., Xiao, M., Zhang, J., & Chen, W. (2018). M1-like tumor-associated macrophages activated by exosome-transferred THBS1 promote malignant migration in oral squamous cell carcinoma. Journal of Experimental & Clinical Cancer Research, 37(1), 1–15.CrossRef
104.
Plebanek, M. P., et al. (2017). Pre-metastatic cancer exosomes induce immune surveillance by patrolling monocytes at the metastatic niche. Nature Communications, 8(1).
105.
Paszek, M. J., Zahir, N., Johnson, K. R., Lakins, J. N., Rozenberg, G. I., Gefen, A., Reinhart-King, C. A., Margulies, S. S., Dembo, M., Boettiger, D., Hammer, D. A., & Weaver, V. M. (2005). Tensional homeostasis and the malignant phenotype. Cancer Cell, 8(3), 241–254.PubMedCrossRef
106.
Lu, P., Weaver, V. M., & Werb, Z. (Feb. 2012). The extracellular matrix: A dynamic niche in cancer progression. The Journal of Cell Biology, 196(4), 395–406.PubMedPubMedCentralCrossRef
107.
Kumar, S., Das, A., & Sen, S. (2018). Multicompartment cell-based modeling of confined migration: Regulation by cell intrinsic and extrinsic factors. Molecular Biology of the Cell, 29(13), 1599–1610.PubMedPubMedCentralCrossRef
108.
Das, A., Barai, A., Monteiro, M., Kumar, S., & Sen, S. (2019). Nuclear softening is essential for protease-independent migration. Matrix Biology, 82, 4–19.PubMedCrossRef
109.
Petrova, V., Annicchiarico-Petruzzelli, M., Melino, G., & Amelio, I. (2018). The hypoxic tumour microenvironment. Oncogenesis, 7(1).
110.
de Jong, O. G., van Balkom, B. W. M., Gremmels, H., & Verhaar, M. C. (2016). Exosomes from hypoxic endothelial cells have increased collagen crosslinking activity through up-regulation of lysyl oxidase-like 2. Journal of Cellular and Molecular Medicine, 20(2), 342–350.PubMedCrossRef
111.
Li, R., et al. (2019). Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis. Molecular Cancer, 18(1), 1–19.PubMedPubMedCentralCrossRef
112.
Hoshino, D., Kirkbride, K. C., Costello, K., Clark, E. S., Sinha, S., Grega-Larson, N., Tyska, M. J., & Weaver, A. M. (2013). Exosome secretion is enhanced by invadopodia and drives invasive behavior. Cell Reports, 5(5), 1159–1168.PubMedCrossRef
113.
Fu, M., Gu, J., Jiang, P., Qian, H., Xu, W., & Zhang, X. (2019). Exosomes in gastric cancer: Roles, mechanisms, and applications. Molecular Cancer, 18(1), 1–12.CrossRef
114.
Zhang, W., Gu, J., Chen, J., Zhang, P., Ji, R., Qian, H., Xu, W., & Zhang, X. (2017). Interaction with neutrophils promotes gastric cancer cell migration and invasion by inducing epithelial-mesenchymal transition. Oncology Reports, 38(5), 2959–2966.PubMedCrossRef
115.
Chen, L., et al. (2018). Exosomes derived from HIV-1-infected cells promote growth and progression of cancer via HIV TAR RNA. Nature Communications, 9(1).
116.
Fedele, C., Singh, A., Zerlanko, B. J., Iozzo, R. V., & Languino, L. R. (2015). The alphavbeta6 integrin is transferred Intercellularly via exosomes. The Journal of Biological Chemistry, 290(8), 4545–4551.PubMedPubMedCentralCrossRef
117.
Helmink, B. A., Khan, M. A. W., Hermann, A., Gopalakrishnan, V., & Wargo, J. A. (2019). The microbiome, cancer, and cancer therapy. Nature Medicine, 25(3), 377–388.PubMedCrossRef
118.
Urbaniak, C., Gloor, G. B., Brackstone, M., Scott, L., Tangney, M., & Reida, G. (2016). The microbiota of breast tissue and its association with breast cancer. Applied and Environmental Microbiology, 82(16), 5039–5048.PubMedPubMedCentralCrossRef
119.
Wei, M. Y., et al. (2019). The microbiota and microbiome in pancreatic cancer: More influential than expected. Molecular Cancer, 18(1), 1–15.CrossRef
120.
L. T. Geller et al., “Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine Leore T. Geller,1* Michal Barzily-Rokni,2* Tal Danino,3† Oliver H. Jonas,4,5 Noam Shental,6 Deborah Nejman,1 Nancy Gavert,1 Yaara Zwang,1 Zachary ,” vol. 1160, no. September, pp. 1156–1160, 2017.
121.
Pushalkar, S., Hundeyin, M., Daley, D., Zambirinis, C. P., Kurz, E., Mishra, A., Mohan, N., Aykut, B., Usyk, M., Torres, L. E., Werba, G., Zhang, K., Guo, Y., Li, Q., Akkad, N., Lall, S., Wadowski, B., Gutierrez, J., Kochen Rossi, J. A., Herzog, J. W., Diskin, B., Torres-Hernandez, A., Leinwand, J., Wang, W., Taunk, P. S., Savadkar, S., Janal, M., Saxena, A., Li, X., Cohen, D., Sartor, R. B., Saxena, D., & Miller, G. (2018). The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression. Cancer Discovery, 8(4), 403–416.PubMedPubMedCentralCrossRef
122.
Schwechheimer, C., & Kuehn, M. J. (2015). Outer-membrane vesicles from gram-negative bacteria: Biogenesis and functions. Nature Reviews. Microbiology, 13(10), 605–619.PubMedPubMedCentralCrossRef
123.
Yu, Y. J., Wang, X. H., & Fan, G. C. (2018). Versatile effects of bacterium-released membrane vesicles on mammalian cells and infectious/inflammatory diseases. Acta Pharmacologica Sinica, 39(4), 514–533.PubMedCrossRef
124.
Sieber, K. B., Bromley, R. E., & Dunning Hotopp, J. C. (2017). Lateral gene transfer between prokaryotes and eukaryotes. Experimental Cell Research, 358(2), 421–426.PubMedPubMedCentralCrossRef
125.
126.
Robinson, K. M., Crabtree, J., Mattick, J. S. A., Anderson, K. E., & Hotopp, J. C. D. (2017). Distinguishing potential bacteria-tumor associations from contamination in a secondary data analysis of public cancer genome sequence data. Microbiome, 5(1), 1–17.CrossRef
127.
Surve, M. V., et al. (2016). Membrane vesicles of group B Streptococcus disrupt Feto-maternal barrier leading to preterm birth. PLoS Pathogens, 12(9), 1–23.CrossRef
128.
Barteneva, N. S., Baiken, Y., Fasler-Kan, E., Alibek, K., Wang, S., Maltsev, N., Ponomarev, E. D., Sautbayeva, Z., Kauanova, S., Moore, A., Beglinger, C., & Vorobjev, I. A. (2017). Extracellular vesicles in gastrointestinal cancer in conjunction with microbiota: On the border of kingdoms. Biochimica et Biophysica Acta, Reviews on Cancer, 1868(2), 372–393.PubMedCrossRef
129.
Housman, G., Byler, S., Heerboth, S., Lapinska, K., Longacre, M., Snyder, N., & Sarkar, S. (2014). Drug resistance in cancer: An overview. Cancers (Basel), 6(3), 1769–1792.CrossRef
130.
131.
Bandari, S. K., Purushothaman, A., Ramani, V. C., Brinkley, G. J., Chandrashekar, D. S., Varambally, S., Mobley, J. A., Zhang, Y., Brown, E. E., Vlodavsky, I., & Sanderson, R. D. (2018). Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior. Matrix Biology, 65(2018), 104–118.PubMedCrossRef
132.
Vlodavsky, I., Gross-Cohen, M., Weissmann, M., Ilan, N., & Sanderson, R. D. (2018). Opposing functions of Heparanase-1 and Heparanase-2 in Cancer progression. Trends in Biochemical Sciences, 43(1), 18–31.PubMedCrossRef
133.
Kamerkar, S., LeBleu, V. S., Sugimoto, H., Yang, S., Ruivo, C. F., Melo, S. A., Lee, J. J., & Kalluri, R. (2017). Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature, 546(7659), 498–503.PubMedPubMedCentralCrossRef
134.
Dimou, A., Syrigos, K. N., & Saif, M. W. (2012). Overcoming the stromal barrier: Technologies to optimize drug delivery in pancreatic cancer. Therapeutic Advances in Medical Oncology, 4(5), 271–279.PubMedPubMedCentralCrossRef
135.
Hoshino, A., Costa-Silva, B., Shen, T. L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., di Giannatale, A., Ceder, S., Singh, S., Williams, C., Soplop, N., Uryu, K., Pharmer, L., King, T., Bojmar, L., Davies, A. E., Ararso, Y., Zhang, T., Zhang, H., Hernandez, J., Weiss, J. M., Dumont-Cole, V. D., Kramer, K., Wexler, L. H., Narendran, A., Schwartz, G. K., Healey, J. H., Sandstrom, P., Jørgen Labori, K., Kure, E. H., Grandgenett, P. M., Hollingsworth, M. A., de Sousa, M., Kaur, S., Jain, M., Mallya, K., Batra, S. K., Jarnagin, W. R., Brady, M. S., Fodstad, O., Muller, V., Pantel, K., Minn, A. J., Bissell, M. J., Garcia, B. A., Kang, Y., Rajasekhar, V. K., Ghajar, C. M., Matei, I., Peinado, H., Bromberg, J., & Lyden, D. (2015). Tumour exosome integrins determine organotropic metastasis. Nature, 527(7578), 329–335.PubMedPubMedCentralCrossRef
136.
Sagar, G., et al. (2017). Pathogenesis of pancreatic Cancer exosome-induced lipolysis in adipose tissue. Gut, 65(7), 1165–1174.CrossRef
137.
Zhou, M., Chen, J., Zhou, L., Chen, W., Ding, G., & Cao, L. (2014). Pancreatic cancer derived exosomes regulate the expression of TLR4 in dendritic cells via miR-203. Cellular Immunology, 292(1–2), 65–69.PubMedCrossRef
138.
Li, Z., Jiang, P., Li, J., Peng, M., Zhao, X., Zhang, X., Chen, K., Zhang, Y., Liu, H., Gan, L., Bi, H., Zhen, P., Zhu, J., & Li, X. (2018). Tumor-derived exosomal lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal adenocarcinoma. Oncogene, 37(28), 3822–3838.PubMedCrossRef
139.
Wang, X., Luo, G., Zhang, K., Cao, J., Huang, C., Jiang, T., Liu, B., Su, L., & Qiu, Z. (2018). Hypoxic tumor-derived exosomal miR-301a mediates M2 macrophage polarization via PTEN/PI3Kg to promote pancreatic cancer metastasis. Cancer Research, 78(16), 4586–4598.PubMedCrossRef
140.
Chiba, M., Kubota, S., Sato, K., & Monzen, S. (2018). Exosomes released from pancreatic cancer cells enhance angiogenic activities via dynamin-dependent endocytosis in endothelial cells in vitro. Scientific Reports, 8(1), 1–9.CrossRef
141.
Melo, S. A., Luecke, L. B., Kahlert, C., Fernandez, A. F., Gammon, S. T., Kaye, J., LeBleu, V. S., Mittendorf, E. A., Weitz, J., Rahbari, N., Reissfelder, C., Pilarsky, C., Fraga, M. F., Piwnica-Worms, D., & Kalluri, R. (2015). Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature, 523(7559), 177–182.PubMedPubMedCentralCrossRef
142.
Lau, C., et al. (2013). Role of pancreatic cancer-derived exosomes in salivary biomarker development. The Journal of Biological Chemistry, 288(37), 2688–2697.CrossRef
143.
Mendt, M., et al. (2018). Generation and testing of clinical-grade exosomes for pancreatic cancer. JCI Insight, 3(8).
144.
Holland, E. C. (2000). Glioblastoma multiforme: The terminator. Proceedings of the National Academy of Sciences of the United States of America, 97(12), 6242–6244.PubMedPubMedCentralCrossRef
145.
Graner, M. W., Cumming, R. I., & Bigner, D. D. (2007). The heat shock response and chaperones/heat shock proteins in brain tumors: Surface expression, release, and possible immune consequences. The Journal of Neuroscience, 27(42), 11214–11227.PubMedPubMedCentralCrossRef
146.
Kore, R. A., & Abraham, E. C. (2014). Inflammatory cytokines, interleukin-1 beta and tumor necrosis factor-alpha, upregulated in glioblastoma multiforme, raise the levels of CRYAB in exosomes secreted by U373 glioma cells. Biochemical and Biophysical Research Communications, 453(3), 326–331.PubMedPubMedCentralCrossRef
147.
Challagundla, K. B., et al. (2015). Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy. Journal of the National Cancer Institute, 107(7), 1–13.CrossRef
148.
Marimpietri, D., et al. (2013). Proteome Profiling of Neuroblastoma-Derived Exosomes Reveal the Expression of Proteins Potentially Involved in Tumor Progression. PLoS One, 8(9).PubMedPubMedCentralCrossRef
149.
Fong, M. Y., Zhou, W., Liu, L., Alontaga, A. Y., Chandra, M., Ashby, J., Chow, A., O’Connor, S. T. F., Li, S., Chin, A. R., Somlo, G., Palomares, M., Li, Z., Tremblay, J. R., Tsuyada, A., Sun, G., Reid, M. A., Wu, X., Swiderski, P., Ren, X., Shi, Y., Kong, M., Zhong, W., Chen, Y., & Wang, S. E. (2015). Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis. Nature Cell Biology, 17(2), 183–194.PubMedPubMedCentralCrossRef
150.
Tominaga, N., et al. (2015). Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier. Nature Communications, 6.
Metadaten
Titel
Exosomes as a storehouse of tissue remodeling proteases and mediators of cancer progression
verfasst von
Alakesh Das
Vishnu Mohan
Venkat Raghavan Krishnaswamy
Inna Solomonov
Irit Sagi
Publikationsdatum
26.11.2019
Verlag
Springer US
Erschienen in
Cancer and Metastasis Reviews / Ausgabe 3/2019
Print ISSN: 0167-7659
Elektronische ISSN: 1573-7233
DOI
https://doi.org/10.1007/s10555-019-09813-5

Weitere Artikel der Ausgabe 3/2019

Cancer and Metastasis Reviews 3/2019 Zur Ausgabe

ReviewPaper

The role of proteases in epithelial-to-mesenchymal cell transitions in cancer

ReviewPaper

KISS1 in breast Cancer progression and autophagy

ReviewPaper

Spatio-temporal modeling and live-cell imaging of proteolysis in the 4D microenvironment of breast cancer

ReviewPaper

Functional disparities within the TIMP family in cancer: hints from molecular divergence

ReviewPaper

The plasminogen activator inhibitor-1 paradox in cancer: a mechanistic understanding

ReviewPaper

Cell surface–anchored serine proteases in cancer progression and metastasis

Neu im Fachgebiet Onkologie

24.04.2024 | DGIM 2024 | Nachrichten

Bei Senioren mit Prostatakarzinom auf Anämie achten!

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

ICI-Therapie in der Schwangerschaft wird gut toleriert

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Krebspatienten impfen: Was? Wen? Und wann nicht?

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Müde im Alter? Auch an die Nebenniere denken
weitere anzeigen

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen